Previous 10 | Next 10 |
RICHMOND HILL, Ontario, July 24, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announces that it will be presenti...
ST. LOUIS, Mo., July 16, 2019 (GLOBE NEWSWIRE) -- Huttig Building Products (Nasdaq: HBP), one of the nation's largest wholesale distributors of millwork and specialty building products used principally in new residential construction and home improvement, plans to release its second quarter...
RICHMOND HILL, Ontario, July 09, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced the submission of ...
RICHMOND HILL, Ontario, June 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announces its financi...
RICHMOND HILL, Ontario, May 30, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced that it has commenced the...
RICHMOND HILL, Ontario, May 29, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it h...
ST. LOUIS, May 06, 2019 (GLOBE NEWSWIRE) -- Huttig Building Products, Inc. (“Huttig” or the “Company”) (NASDAQ: HBP), a leading domestic distributor of millwork, building materials and wood products, announced today that its Board of Directors has approved an ame...
Huttig Building Products, Inc. (HBP) Q1 2019 Earnings Conference Call April 30, 2019 11:00 AM ET Company Participants Jon Vrabely - President, Chief Executive Officer and Director Philip Keipp - Chief Financial Officer and Executive Vice President Bob Furio - Executive Vice Presi...
RICHMOND HILL, Ontario, May 01, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, has announced that the Trial Steeri...
Huttig Building Products ( HBP -5.4% ) reported net sales of $197.4M a slight decrease of 0.3% Y/Y, due to lower market activity and severe weather. More news on: Huttig Building Products, Inc., Earnings news and commentary, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Huttig Building Products Inc. Company Name:
HBP Stock Symbol:
NASDAQ Market:
Huttig Building Products Inc. Website:
--News Direct-- Toronto, Ontario – TheNewswire – December 14, 2023 – Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based o...
(TheNewswire) Toronto, Ontario - TheNewswire - October 27, 2023 - Helix BioPharma Corp. (TSX:HBP) , (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immu...
--News Direct-- Toronto, Ontario - TheNewswire - October 10, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), an immune-oncology antibody-drug-conjugate company developing an innovative drug platform for the treatment of cancer, announced today th...